| Identification | Back Directory | [Name]
Fmoc-PEG2-NHS ester | [CAS]
1807534-85-5 | [Synonyms]
Fmoc-PEG2-NHS ester
FmocNH-PEG2-NHS?ester
Fmoc-PEG2-C2-NHS ester
FmocNH-PEG2-CH2CH2COONHS
Fmoc-N-amido-PEG2-NHS ester
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(9~{H}-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]propanoate | [Molecular Formula]
C26H28N2O8 | [MDL Number]
MFCD28142470 | [MOL File]
1807534-85-5.mol | [Molecular Weight]
496.51 |
| Chemical Properties | Back Directory | [density ]
1.35±0.1 g/cm3(Predicted) | [storage temp. ]
Storage temp. -20°C | [form ]
Solid-Liquid Mixture | [pka]
11.60±0.46(Predicted) | [color ]
Colorless to off-white |
| Hazard Information | Back Directory | [Description]
Fmoc-PEG2-NHS ester is a PEG linker containing an Fmoc-protected amine and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. | [Uses]
Fmoc-PEG2-CH2CH2-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | [IC 50]
PEGs; Alkyl/ether | [References]
[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
|
| Company Name: |
T&W GROUP
|
| Telephone: |
021-61551611 13296011611 |
| Website: |
www.trustwe.com/ |
| Company Name: |
Borenpharm Co., Ltd
|
| Telephone: |
027-65563561 13026317987; |
| Website: |
http://www.borenpharm.com |
| Company Name: |
Nextpeptide Inc
|
| Telephone: |
+86-0571-81612335 +8613336028439 |
| Website: |
http://www.nextpeptide.com/ |
| Company Name: |
Wuhan Topule
|
| Telephone: |
+86-02787215551 19945035818 |
| Website: |
http://www.topule.com/ |
|